accord
new
estim
joint
unit
nation
programm
human
immunodefici
viru
hiv
acquir
immunodefici
syndrom
aid
unaid
world
health
organ
million
adult
live
hiv
close
total
hivposit
peopl
sub
haran
africa
diarrheal
ill
remain
major
clinic
problem
patient
infect
hn
particularli
lifethreaten
aid
africa
diarrhea
occur
hiv
infect
slim
diseas
prolong
diarrhea
wast
usual
attribut
coccidian
parasit
pathognom
aid
central
africa
seto
preval
hiv
seneg
nearli
adult
aid
present
initi
diarrhea
weight
loss
wide
varieti
bacteri
viral
parasit
pathogen
caus
diarrhea
patient
advanc
hiv
infect
although
diarrhea
occur
frequent
optim
manag
remain
bacteri
pathogen
aid
patient
may
manifest
differ
infect
immunocompet
host
pathogen
includ
cryptosporidium
microsporidium
difficult
diagnos
effect
therapi
moreov
enter
virus
hiv
may
contribut
diarrhea
limit
inform
avail
regard
etiolog
clinic
consequ
immunolog
effect
infect
diarrheal
agent
immunocompromis
host
consequ
author
conduct
survey
seneg
among
hivseroposit
hivseroneg
subject
identifi
major
type
preval
bacteria
parasit
fungi
rotavirus
associ
diarrhea
adult
patient
goal
provid
guidanc
physician
case
manag
four
group
patient
hospit
two
senegales
hospit
hopita
princip
fann
teach
hospit
examin
group
compris
hivinfect
patient
diarrhea
hiv
group
hiv
seroneg
patient
diarrhea
hivd
group
hivinfect
patient
without
diarrhea
hiv
group
hiv
seroneg
control
without
diarrhea
hivd
control
stool
specimen
group
group
obtain
hivseroposit
hivseroneg
adult
select
individu
histori
diarrheal
ill
preced
month
case
group
group
hivseroposit
hivseroneg
hospit
adult
diarrhea
receiv
antibiot
previou
week
subject
underw
complet
physic
examin
patient
environ
histori
record
standard
questionnair
fill
physician
aspect
studi
approv
ad
hoc
ethic
committe
prior
inform
consent
obtain
includ
subject
human
immunodefici
viru
serolog
test
two
enzym
immunoassay
genelavia
mixt
sanofi
diagnost
pasteur
marrieslacoquett
franc
vironostika
hiv
uniform
ii
organon
teknika
boxtel
netherland
confirm
western
blot
new
iav
blot
sanofi
diagnost
pasteur
lymphocyt
count
undertaken
use
laserbas
facscount
system
becton
dickinson
irnmunocytometri
system
san
jose
ca
usa
directli
determin
absolut
count
case
control
stool
specimen
collect
process
way
transport
media
use
specimen
quickli
examin
laboratori
collect
freshli
collect
stool
sampl
examin
immedi
collect
darkfield
microscopi
motil
bacteria
trophozoit
red
blood
cell
leukocyt
stool
specimen
treat
salin
iodin
prepar
examin
intestin
parasit
furthermor
formalineth
concentr
smear
stain
merthiolateiodineformaldehyd
solut
prepar
specimen
examin
microscop
coccidia
microsporidia
detect
respect
kinyoun
stain
modifi
trichrom
stain
high
concentr
chromotrop
modifi
kinyoun
acidfast
stain
use
detect
mycobacteria
rotavirus
identifi
commerci
latex
agglutin
test
sanofi
diagnost
pasteur
bacteria
escberichia
coli
salmonella
spp
shigella
spp
yersinia
spp
aeromona
spp
plesiomona
spp
vibrio
spp
campylobact
spp
fungi
identifi
standard
identif
czostridium
spp
undertaken
gramposit
rod
seen
gram
stain
genotyp
differenti
pathogen
e
coli
strain
perform
polymeras
chain
reaction
pcr
accord
tornieporth
et
al
oligonucleotid
primer
detect
enterotoxigen
e
coli
etec
enteroinvas
e
coli
eiec
enterohemorrhag
e
coli
ehec
enteropathogen
e
coli
epec
enteroaggreg
e
coli
ilaggec
diffus
adher
e
coli
daec
pcr
test
shown
tabl
phenotyp
character
pathogen
e
coli
perform
microtit
gangliosid
enzym
link
immunosorb
assay
gmlelisa
thermolabil
enterotoxin
suckl
mous
assay
thermost
enterotoxin
guinea
pig
keratoconjunct
assay
enteroinvas
e
coli
e
coli
isol
examin
cell
adher
eightwel
chamber
slide
labtek
nunc
inc
napervil
il
usa
accord
vial
et
al
cell
adher
character
local
ia
aggreg
aa
diffus
da
adher
adher
pattern
virul
gene
perform
five
coloni
e
coli
escherichia
coli
consid
etiolog
agent
diarrheal
ill
signific
virul
gene
identifi
least
three
five
test
coloni
serotyp
salmonella
spp
shigezza
spp
determin
use
slide
agglutinationth
antimicrobi
suscept
bacteri
enteropathogen
determin
use
disk
diffus
stastic
analys
perform
use
epi
info
version
center
diseas
control
prevent
atlanta
ga
usa
sa
version
sa
inc
gari
nc
usa
continu
variabl
normal
distribut
mean
compar
use
student
ttest
analysi
varianc
categor
variabl
compar
use
cmsquar
test
fisher
exact
test
appropri
potenti
risk
factor
diarrhea
among
hivinfect
individu
analyz
univari
method
determin
possibl
inclus
multivari
model
variabl
associ
diarrhea
pvalu
less
includ
multivari
analysi
logist
regress
analysi
perform
calcul
odd
ratio
confid
interv
cd
among
stool
blood
sampl
analyz
case
controlsth
characterist
studi
popul
describ
tabl
frequent
serotyp
hivl
identifi
popul
identifi
studi
popul
coinfect
serotyp
hivl
expect
geometr
mean
cell
count
lower
hivinfect
hivseroneg
patient
case
well
control
p
count
also
significantli
lower
diarrheic
patient
hiv
p
well
hiv
p
patient
signific
differ
age
gender
among
four
group
identifi
bacteri
pathogen
list
tabl
yersinia
spp
vibrio
spp
plesiomona
spp
ehec
clostridium
perfringen
mycobacterium
spp
identifi
studi
shigella
spp
salmonella
spp
frequent
identifi
bacteri
pathogen
acut
diarrhea
shigella
identifi
sbigella
jlexneri
n
shigella
dysenteria
n
shigella
sonnei
n
shigella
boydii
identifi
shigella
strain
case
except
one
sonnei
isol
hivseroneg
patient
without
diarrhea
asymptomat
carriag
shigella
observ
hivinfect
patient
eighteen
strain
salmonella
enterica
case
control
identifi
variou
serotyp
enteritidi
among
case
among
control
kentacki
among
case
typhi
among
case
sangera
among
case
magherafelt
among
case
tambacounda
among
case
among
control
glostrup
among
case
typhimurium
tabl
concern
preval
differ
e
coli
pathotyp
identifi
pcr
see
tabl
least
one
target
gene
found
patient
target
gene
found
often
case
control
p
result
show
high
preval
afa
gene
case
well
control
consequ
pathogen
e
coli
e
coli
strain
least
one
virul
factor
differ
afu
gene
invers
enteroaggreg
enteroinvas
e
coli
seem
close
relat
respect
chronic
acut
diarrhea
isol
enteroinvas
e
coli
ipah
gene
depend
hivserostatu
asymptomat
carriag
found
pathotyp
contrast
enteroaggreg
e
coli
eagg
gene
isol
frequent
hivseroposit
patient
one
strain
e
coli
carri
three
virul
gene
afu
eae
eagg
identifi
hivseroposit
patient
chronic
diarrhea
except
ipah
gene
virul
gene
identifi
patient
count
rang
good
correl
genotyp
phenotyp
character
enterotoxigen
enteroinvas
e
coli
two
strain
posit
gmlelba
test
heatlabil
enterotoxin
suckl
mous
model
assay
heatstabl
enterotoxin
strain
carri
ah
gene
posit
guinea
pig
keratoconjunct
sereni
test
unusu
bacteri
etiolog
like
klebsiella
pneumonia
n
citrobact
freundii
n
found
immunocompromis
patient
diarrhea
one
citrobact
spp
strain
isol
yearold
hivseroneg
woman
diabet
strain
hivseroposit
patient
low
count
case
oral
antibiot
therapi
prove
effect
opportunist
bacteri
pathogen
examin
cell
adher
show
diffus
adher
pattern
except
three
strain
k
pneumonia
display
stackedbrick
aggreg
adher
pattern
typic
enteroaggreg
e
coli
strain
one
strain
c
freundii
differ
one
isol
woman
display
local
adher
attach
effac
pattern
typic
enteropathogen
e
coli
polymeras
chain
reaction
e
coli
virul
gene
neg
almost
strain
except
one
kpneumonia
eagg
gene
one
c
freundii
gene
eae
gene
tabl
illustr
antibiot
suscept
strain
bacteri
enteropathogen
recov
case
control
isol
suscept
gentamicin
broadspectrum
cephalosporin
ciprofloxacin
shigella
spp
pathogen
e
coli
highli
resist
ampicillin
ticarcillin
cotrimoxazol
tetracyclin
enteropathogen
strain
remain
suscept
ampicillin
clavulan
acid
third
gener
cephalosporin
fluoroquinolon
interestingli
salmonella
strain
remain
suscept
almost
antibiot
except
tetracyclin
preval
differ
parasit
c
albican
rotavirus
shown
tabl
high
level
asymptomat
carriag
lumbricoid
trichuri
trichiura
observ
immunocompet
patient
two
main
parasit
agent
involv
diarrhea
entamoeba
histolytica
giardia
lamblia
main
opportunist
parasit
microsporidium
cryptosporidium
isospora
belli
salmonella
spp
microsporidium
n
l
cryptosporidium
lumbricoid
n
l
salmonella
g
lamblia
trichiura
n
l
microsporidium
e
coli
lumbricoid
n
belli
trichuria
lumbricoid
n
l
cryptosporidium
c
albican
n
shigella
lumbricoid
n
risk
develop
diarrhea
increas
progress
count
fell
cellsmm
tabl
independ
risk
factor
poor
hous
also
patient
younger
year
age
tend
higher
risk
diarrhea
promin
featur
aid
adult
caus
signific
morbid
hivinfect
person
studi
confirm
associ
persist
diarrhea
enteroaggreg
e
coli
previous
suspect
countri
howev
isol
group
patient
display
stack
brick
aggreg
adher
pattern
cell
lack
typic
virul
factor
enteroaggreg
e
coli
strain
eaggec
gene
phenomenon
observ
investig
suggest
exist
virul
factor
current
result
suggest
afa
gene
signific
virul
gene
adult
seneg
often
associ
e
cod
individu
age
group
alarm
rate
resist
afford
antibiot
found
dakar
tetracyclin
cotrimoxazol
provid
evid
need
ration
use
antibiot
fact
high
resist
tetracyclin
emerg
seneg
intens
use
drug
cholera
epidem
present
studi
case
diarrhea
unknown
etiolog
extens
evalu
includ
stool
studi
endoscop
biopsi
colon
small
intestin
wide
recommend
identifi
potenti
pathogen
organ
stool
virus
adenoviru
coronaviru
describ
possibl
caus
diarrhea
hivinfect
patient
berlin
l
unusu
pathogen
spirochet
describ
possibl
caus
diarrhea
hivinfect
person
central
african
republ
moreov
enter
virus
hiv
may
contribut
diarrhea
addit
microb
factor
medic
immun
dysregul
automat
dysfunct
nutrit
supplement
play
substanti
role
diarrhea
patient
aid
present
find
suggest
coccidia
consid
etiolog
agent
immunocompromis
adult
result
observ
develop
african
conflict
evid
exist
whether
b
homini
also
includ
among
infecti
agent
capabl
caus
hivrel
diarrhea
albrecht
et
al
found
associ
b
homini
clinic
symptom
evid
frequent
associ
concurr
isol
enter
pathogen
present
studi
b
homini
consid
opportunist
parasit
identifi
hivinfect
patient
higher
preval
adult
diarrhea
case
associ
pathogen
found
result
studi
suggest
declin
tlymphocyt
count
associ
increas
risk
diarrhea
furthermor
ftnding
lower
count
among
patient
diarrhea
regardless
hiv
serostatu
show
diarrhea
debilit
ill
suggest
effect
manag
diarrhea
prevent
lmnmnosuppress
principl
hiv
aid
therapi
includ
reduct
hiv
replic
antiretrovlr
agent
prophylaxi
common
opportunist
infect
treatment
follow
subsequ
lifelong
mainten
therapi
infect
mani
develop
countri
afford
antiretroviml
therapi
therefor
effect
manag
opportunist
infect
includ
diarrheal
diseas
remain
realist
altern
improv
qualiti
life
patient
live
hiv
delay
evolut
aid
guidelin
manag
bacteri
diarrhea
develop
countri
updat
studi
cotrimoxazol
one
recommend
antimicrobi
agent
treatment
diarrhea
shown
littl
activ
shigella
spp
salmonella
spp
enteroaggreg
e
coli
